Jaguar Health (JAGX) EBT Margin (2015 - 2026)
Jaguar Health (JAGX) posted quarterly EBT Margin of 43.03% for Q1 2026, up 52162.0% year-over-year from N/an in Q1 2025, and up 106.0% quarter-over-quarter from 716.94% in Q4 2025.
Jaguar Health (JAGX) EBT Margin (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported EBT Margin for 12 consecutive years, with 43.03% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT Margin rose 52162.0% year-over-year to 43.03%; the TTM figure through Mar 2026 stood at 117.28% (up 23313.0% YoY), while the FY2025 annual figure was 469.09%, down 13330.0% from the prior year.
- EBT Margin grew to 43.03% in Q1 2026 per JAGX's latest filing, from 716.94% in the prior quarter.
- Across five years, EBT Margin topped out at 43.03% in Q1 2026 and bottomed at 90820.0% in Q1 2022.
- Historically, EBT Margin has averaged 8773.98% across 5 years, with a median of 398.47% in 2024.
- Annual changes were most pronounced in 2022 — EBT Margin sank 8982588 bps — and 2023, when it surged 6327111 bps.
- Jaguar Health's EBT Margin stood at 25725.0% in 2022, then jumped by 98 bps to 404.74% in 2023, then gained by 28 bps to 291.65% in 2024, then slumped by 146 bps to 716.94% in 2025, then soared by 106 bps to 43.03% in 2026.
- Business Quant data shows JAGX's EBT Margin at 43.03% in Q1 2026, 716.94% in Q4 2025, and 312.94% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Jaguar Health | 452,552.38 | -9.61 Mn | 19.11 Mn | 43.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.03% |
| Dec 31, 2025 | -716.94% |
| Sep 30, 2025 | -312.94% |
| Jun 30, 2025 | -354.48% |
| Mar 31, 2025 | -478.59% |
| Dec 31, 2024 | -291.65% |
| Sep 30, 2024 | -322.43% |
| Jun 30, 2024 | -353.84% |
| Mar 31, 2024 | -398.47% |
| Dec 31, 2023 | -404.74% |
| Sep 30, 2023 | -280.98% |
| Jun 30, 2023 | -467.87% |
| Mar 31, 2023 | -27,548.89% |
| Dec 31, 2022 | -25,725.00% |
| Sep 30, 2022 | -402.46% |
| Jun 30, 2022 | -321.47% |
| Mar 31, 2022 | -90,820.00% |
| Dec 31, 2021 | -688.37% |
| Sep 30, 2021 | -1,982.44% |
| Jun 30, 2021 | -3,715.30% |